Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Deferred Taxes (2020 - 2021)

Historic Deferred Taxes for Exagen (XGN) over the last 2 years, with Q4 2021 value amounting to $148000.0.

  • Exagen's Deferred Taxes rose 124545.45% to $148000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $148000.0, marking a year-over-year increase of 23962.26%. This contributed to the annual value of -$306000.0 for FY2022, which is 30675.68% down from last year.
  • Latest data reveals that Exagen reported Deferred Taxes of $148000.0 as of Q4 2021, which was up 124545.45% from $11000.0 recorded in Q4 2020.
  • Over the past 5 years, Exagen's Deferred Taxes peaked at $148000.0 during Q4 2021, and registered a low of -$117000.0 during Q1 2020.